Immune cells can become exhausted after prolonged exposure to cancer, gradually losing their ability to attack tumor cells.
Spun out of research at Seattle Children’s Hospital, the startup has brought a CAR-T treatment for a rare and deadly ...
BrainChild Bio has raised $116 million in Series A funding to advance its CAR T cell therapies for central nervous system ...
ILLUMINATE Phase 2 pivotal study will enroll patients at six leading pediatric oncology centers across the U.S.B7-H3-targeted autologous CAR T ...
Scientists created smart nanoparticles that can both illuminate hidden glioblastoma cells during surgery and destroy ...
Brain tumors do not grow in isolation. They develop within the highly active environment of the brain, where neurons ...
A new phase 1 clinical trial has found that an emerging immunotherapy is promising for treating recurrent glioblastoma, a ...
Scientists at St. Jude Children's Research Hospital have shown that specific brain cells respond differently to H3.3 K27M, a ...
Immune cells can become exhausted after prolonged exposure to cancer, gradually losing their ability to attack tumor cells.
The devices make tumour-on-a-chip technology easier and cheaper to build, with the hope they can be moved into clinical use ...
Brain tumors do not grow in isolation. They develop within the highly active environment of the brain, where neurons ...
UCLA researchers have discovered two powerful influences that help guide how the human brain forms before birth. Radial glia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results